Market Place
Sourcing Support
Mainz Biomed to Present mRNA Biomarker Data at DDW
24 Feb 2026 //
GLOBENEWSWIRE
Mainz Biomed`s Pancreatic Cancer Study Heads to AACR 2026
14 Jan 2026 //
GLOBENEWSWIRE
Mainz Biomed Provides Review Of 2025 Highlights
05 Jan 2026 //
GLOBENEWSWIRE
Doctorbox Adds Mainz Biomed`s Coloalert(R) To Its Portfolio
02 Dec 2025 //
GLOBENEWSWIRE
Mainz Biomed, Oncovanguard8 Partner To Introduce Coloalert
18 Nov 2025 //
GLOBENEWSWIRE
Mainz Biomed Unveils Cancer Detection Innovations at MEDICA 2025
12 Nov 2025 //
GLOBENEWSWIRE
Mainz Biomed To Attend 2025 Maxim Growth Summit
15 Oct 2025 //
GLOBENEWSWIRE
Mainz Bio Reports Feasibility Results In Pancreatic Cancer Study
08 Oct 2025 //
GLOBENEWSWIRE
Mainz Biomed Launches Coloalert® In Switzerland
23 Sep 2025 //
GLOBENEWSWIRE
Mainz Biomed Registers ColoAlert in the UK
02 Sep 2025 //
GLOBENEWSWIRE
Mainz Biomed Gets Swiss Approval for ColoAlert® Marketing
13 Aug 2025 //
GLOBENEWSWIRE
Mainz Biomed Prices $3.0 M Follow-On Offering of Shares
04 Aug 2025 //
GLOBENEWSWIRE
Mainz Biomed partners with EDX Medical Group
29 Apr 2025 //
GLOBENEWSWIRE
Mainz Biomed Enrolls First Patient in eAArly DETECT 2 Study
27 Mar 2025 //
GLOBENEWSWIRE
Mainz Biomed & Liquid Discover mRNA Biomarkers for Pancreatic Cancer
13 Mar 2025 //
GLOBENEWSWIRE
Mainz Biomed Expands into Switzerland with labor team w
20 Feb 2025 //
GLOBENEWSWIRE
Mainz Biomed Regains Compliance With Nasdaq Listing Rules
27 Jan 2025 //
GLOBENEWSWIRE
Mainz Begins Study On Adenoma Test Performance In Large Population
21 Jan 2025 //
GLOBENEWSWIRE
Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering
16 Dec 2024 //
GLOBENEWSWIRE
Mainz Biomed Prices $8.0M Follow-On Offering Under Nasdaq Rules
12 Dec 2024 //
GLOBENEWSWIRE
Mainz Biomed Announces Stock Split
29 Nov 2024 //
GLOBENEWSWIRE
Mainz & Thermo Fisher Collaborate on Colorectal Cancer Screening
12 Nov 2024 //
GLOBENEWSWIRE
Mainz Biomed Reports Mid-Year 2024 Financial Results And Update
21 Oct 2024 //
GLOBENEWSWIRE
Mainz Biomed CEO Eyes Growth and FDA Trials in 2025
01 Oct 2024 //
GLOBENEWSWIRE
Mainz Biomed Appoints Petra Smeltzer Starke As Ambassador
18 Sep 2024 //
GLOBENEWSWIRE
Mainz Biomed Partners With Liquid Biosciences For PancAlert
04 Sep 2024 //
GLOBENEWSWIRE
Mainz Biomed to present results from colorectal cancer screening at DDW 2024
09 May 2024 //
PHARMABIZ
Mainz Reports Positive CRC Biomarker AI Algorithm Results
25 Apr 2024 //
GLOBENEWSWIRE
Mainz Biomed and TestDNA Drive CRC Innovation at the Gastroenterology Symposium
11 Jan 2024 //
GLOBENEWSWIRE
Mainz Biomed Reports Positive Topline Results Evaluating Novel mRNA Biomarkers
05 Dec 2023 //
GLOBENEWSWIRE
Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference
20 Sep 2023 //
GLOBENEWSWIRE
Mainz Biomed Announces Strategic Partnership with rztliches Labor Dr. Buhlmann
05 Sep 2023 //
GLOBENEWSWIRE
Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference
29 Aug 2023 //
GLOBENEWSWIRE
Mainz Bio Announces Live Launch of ColoAlert® with Marylebone Laboratory in UK
01 Aug 2023 //
GLOBENEWSWIRE
Mainz Biomed Announces Collaboration with Fugene Genetics in Israel
18 Jul 2023 //
GLOBENEWSWIRE
Mainz Biomed Secures up to $50M in New Funding
29 Jun 2023 //
GLOBENEWSWIRE
Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023
28 Jun 2023 //
GLOBENEWSWIRE
Mainz Biomed Provides Full Year 2022 Financial Results
10 Apr 2023 //
GLOBENEWSWIRE
Mainz Biomed Expands Corporate Health Program for ColoAlert
04 Apr 2023 //
GLOBENEWSWIRE
Mainz Biomed Reports Positive Results from Study Evaluating mRNA Biomarkers
29 Mar 2023 //
GLOBENEWSWIRE
Mainz Biomed Provides Year-End 2022 Corporate Review
03 Jan 2023 //
GLOBENEWSWIRE
